Literature DB >> 31070800

The design modification of advanced ventricular assist device to enhance pulse augmentation and regurgitant flow shut-off.

Takuma Miyamoto1, Nicole Byram1, Jamshid H Karimov1, Joseph Adams1, Raymond Dessoffy1, Barry D Kuban1,2, Shengqiang Gao2, David J Horvath3, Kiyotaka Fukamachi1.   

Abstract

The new Advanced ventricular assist device (Advanced VAD) has many features such as improving pulsatility and preventing regurgitant flow during pump stoppage. The purpose of this study was to evaluate the effects of design modifications of the Advanced VAD on these features in vitro. Bench testing of four versions of the Advanced VAD was performed on a static or pulsatile mock loop with a pneumatic device. After pump performance was evaluated, each pump was run at 3000 rpm to evaluate pulse augmentation, then was stopped to assess regurgitant flow through the pump. There was no significant difference in pump performance between the pump models. The average pulse pressure in the pulsatile mock loop was 23.0, 34.0, 39.3, 33.8, and 37.3 mm Hg without pump, with AV010, AV020 3S, AV020 6S, and AV020 RC, respectively. The pulse augmentation factor was 48%, 71%, 47%, and 62% with AV010, AV020 3S, AV020 6S, and AV020 RC, respectively. In the pump stop test, regurgitant flow was -0.60 ± 0.70, -0.13 ± 0.57, -0.14 ± 0.09, and -0.18 ± 0.06 L/min in AV010, AV020 3S, AV020 6S, and AV020 RC, respectively. In conclusion, by modifying the design of the Advanced VAD, we successfully showed the improved pulsatility augmentation and regurgitant flow shut-off features.
© 2019 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.

Keywords:  continuous flow; in vitro; mock loop; pulsatility; pump performance; pump weanability

Mesh:

Year:  2019        PMID: 31070800     DOI: 10.1111/aor.13484

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  4 in total

1.  Universal ventricular assist device for right and left circulatory support: the Cleveland Clinic concept.

Authors:  Jamshid H Karimov; Anthony R Polakowski; Kiyotaka Fukamachi; Takuma Miyamoto; Christine Flick
Journal:  Ann Cardiothorac Surg       Date:  2021-03

2.  Characterization and Development of Universal Ventricular Assist Device: Computational Fluid Dynamics Analysis of Advanced Design.

Authors:  Mark S Goodin; Michael S Showalter; David J Horvath; Barry D Kuban; Christine R Flick; Anthony R Polakowski; Kiyotaka Fukamachi; Jamshid H Karimov
Journal:  ASAIO J       Date:  2021-11-10       Impact factor: 3.826

3.  An advanced universal circulatory assist device for left and right ventricular support: First report of an acute in vivo implant.

Authors:  Takuma Miyamoto; Yuichiro Kado; David J Horvath; Barry D Kuban; Shiva Sale; Kiyotaka Fukamachi; Jamshid H Karimov
Journal:  JTCVS Open       Date:  2020-06-20

Review 4.  Mechanical circulatory support devices and treatment strategies for right heart failure.

Authors:  Taiyo Kuroda; Chihiro Miyagi; Kiyotaka Fukamachi; Jamshid H Karimov
Journal:  Front Cardiovasc Med       Date:  2022-09-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.